Featured Research

from universities, journals, and other organizations

Penn Researchers Create Drug To Help Target Attack On Cancerous Tumors

Date:
March 2, 1998
Source:
University Of Pennsylvania Medical Center
Summary:
Researchers at the University of Pennsylvania Cancer Center have developed a drug that will help doctors fine- tune cancer treatments to patients. The drug, EF5, permits doctors to effectively determine the oxygen content of a tumor-- which subsequently dictates the appropriate course of treatment to be followed.

Philadelphia, PA -- Researchers at the University of Pennsylvania Cancer Center have developed a drug that will help doctors fine- tune cancer treatments to patients. The drug, EF5, permits doctors to effectively determine the oxygen content of a tumor-- which subsequently dictates the appropriate course of treatment to be followed.

Cancer clinicians have long known that hypoxic tumors--which thrive in oxygen-starved environments--are much more resistant to radiation and chemotherapy than their non-hypoxic cousins. But until now, physicians have had difficulty assessing hypoxicity

"When we know which tumors are hypoxic, we'll be able to custom-tailor a patient's cancer treatment," says Gillies McKenna, MD, Chair of Radiation Oncology at the University of Pennsylvania Cancer Center. "This may mean prescribing a more aggressive form of therapy, such as modifying the way radiation is delivered, or giving radiation in combination with drugs designed to exploit the hypoxic nature of the tumor," says McKenna.

EF5, developed by Cameron J. Koch, PhD, Professor of Radiation Oncology, was recently approved by the FDA for a Phase I clinical trial at the University of Pennsylvania Medical Center.

Patients with early stage cervix tumors, located at the neck of the uterus, and soft tissue sarcomas, are given EF5 intravenously two days before their tumors are surgically removed or biopsied. During this time, EF5 attaches or "binds" to hypoxic tumor cells, but "washes out" of tumor regions that are oxygen-rich. A small portion of the tumor, removed at surgery, is then exposed to fluorescent monoclonal antibodies.* These antibodies fasten to the hypoxic regions in the tumor and highlight its oxygen content.

Sydney Evans, VMD, Assistant Professor of Veterinary Medicine, has spent the last several years demonstrating the safety and efficacy of EF5 in animal tumor models and says that EF5 has shown no toxicity in animal studies.

In the trial, a second method of measuring hypoxia is also employed where a thin needle electrode is inserted into the tumor to measure the oxygen content. The needle electrode measures the amount of oxygen along the track of the needle. "Using the needle electrode is currently considered the standard method for measuring the tumor's oxygen content. However, by using EF5 with the needle electrode, we will have more precise information as to the amount and location of the oxygen within the entire tumor. Hopefully, it will increase the accuracy of tumor hypoxia diagnosis," Koch explains.

In the future, Penn researchers hope to adapt the EF5 technique for use with the Positron Emission Tomography (PET) imaging, which will allow for a non-invasive procedure of identifying the oxygen content within the patient's tumor. "Applications of this drug are far-reaching," says Evans. "We'll be able to non-invasively examine the binding of EF5 for other diseases in which hypoxia occurs, such as heart attacks and strokes, in addition to the use in cancer."

###*The fluorescent monoclonal antibodies were developed by Dr. Edith M. Lord, of the University of Rochester Cancer Center.


Story Source:

The above story is based on materials provided by University Of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pennsylvania Medical Center. "Penn Researchers Create Drug To Help Target Attack On Cancerous Tumors." ScienceDaily. ScienceDaily, 2 March 1998. <www.sciencedaily.com/releases/1998/03/980302070943.htm>.
University Of Pennsylvania Medical Center. (1998, March 2). Penn Researchers Create Drug To Help Target Attack On Cancerous Tumors. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/1998/03/980302070943.htm
University Of Pennsylvania Medical Center. "Penn Researchers Create Drug To Help Target Attack On Cancerous Tumors." ScienceDaily. www.sciencedaily.com/releases/1998/03/980302070943.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins